The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki
The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki The Mitochondrial Free Radical Theory of Aging - Supernova: Pliki
Prospects for Intervention Fig. 13.1. See opposite page. 13.2. A Way to Obviate mtDNA The proteins encoded in the mtDNA are vital, integral components of the OXPHOS machinery. In rejecting option i, I have thus already accepted that these genes are indispensable. What is not so clear, however, is that they need to be carried in mitochondria. Could we not make copies of those genes and incorporate them into cells’ nuclear DNA? 169
170 The Mitochondrial Free Radical Theory of Aging These copies would be vastly less prone to spontaneous mutation than their mitochondrially-located counterparts, since they would be 1. far from mitochondria and the LECs they produce, 2. safe from replication error, since the nuclear DNA of non-dividing cells (which are the ones that matter) does not replicate, and 3. safe from the huge selective pressure for mutations that affects mitochondrially-located DNA. When a mtDNA mutation occurs, it will then not matter whether or not it is amplified, because the protein products of the mutant gene will not be necessary to the host mitochondrion. (And anyway, SOS predicts that it will actually not be amplified, because the host mitochondrion will be generating a normal proton gradient using the nuclear-coded protein.) In genetic terminology, the nuclear copy will complement the mutant mitochondrial one. This technique is termed allotopic expression of the mtDNA genes. There are numerous difficulties with this treatment. In focusing on it, I am in no way belittling these difficulties; all I claim is that none of them is so great as those which confront the alternative approaches rejected above. They will be discussed in detail in Chapter 15. 13.3. A Way to Destroy Anaerobic Cells Next, consider option j. Its logic is that OXPHOS collapse of only 1% of cells would be perfectly tolerable if it did not affect all the rest of our cells so badly. If those cells were removed, therefore, we would not suffer noticeably from their absence and we would benefit greatly from the loss of their toxic electrons. Accordingly, I think their removal is a plausible avenue for intervention, and I will examine it in detail in Chapter 14. This option for retarding aging has one clear advantage relative to complementation of mtDNA and one clear disadvantage. The disadvantage is that, unless and until ways are found to stimulate replacement of the ablated cells, there would be a steady—albeit slow—decline in the functionality of non-dividing tissues. This will be addressed further in Section 14.4. The advantage is that such a treatment may be developable—to a degree of reliability that makes it useful—more quickly than the complementation of mtDNA. This is because complementation of mtDNA by nuclear genes will definitely not be possible without gene therapy, whereas ablation of anaerobic cells may well be achievable by simpler technology. A discussion of what gene therapy is (and aims to become) is therefore appropriate. 13.4. Gene Therapy Gene therapy is the treatment of a medical condition by adding DNA to a patient’s cells. The DNA that one would add depends, naturally, on the condition which is being treated; in principle one can add whatever DNA one wants. In general one would want to add new, intact copies of genes whose existing copies were mutant, thus relieving the symptoms of the mutant genes. Development of treatments involving gene therapy really breaks into two parts: design and delivery. That is: 1. figure out what DNA to insert into the nucleus in order to achieve the effect; 2. figure out how to actually get that DNA into the nucleus of our cells. 13.4.1. How Close Is It? Delivery of DNA to cells is very complex. Luckily, however, it is the same for any DNA, and there are plenty of ailments other than aging which are caused by mutations and which could be treated by inserting new DNA. Thus, there is already a huge research effort worldwide seeking ways to do this. As with any technological advance, no one really knows how long it
- Page 123 and 124: Frequently-Asked Questions The effe
- Page 125 and 126: Frequently-Asked Questions Table 10
- Page 127 and 128: Frequently-Asked Questions through
- Page 129 and 130: Frequently-Asked Questions has been
- Page 131 and 132: Frequently-Asked Questions SOS, sin
- Page 133 and 134: Frequently-Asked Questions for almo
- Page 135 and 136: Frequently-Asked Questions Fig. 10.
- Page 137 and 138: Frequently-Asked Questions Fig. 10.
- Page 139 and 140: Frequently-Asked Questions of elect
- Page 141 and 142: Frequently-Asked Questions Referenc
- Page 143 and 144: Frequently-Asked Questions 45. Clay
- Page 145 and 146: CHAPTER 11 A Challenge from Textboo
- Page 147 and 148: A Challenge from Textbook Bioenerge
- Page 149 and 150: A Challenge from Textbook Bioenerge
- Page 151 and 152: A Challenge from Textbook Bioenerge
- Page 153 and 154: A Challenge from Textbook Bioenerge
- Page 155 and 156: A Challenge from Textbook Bioenerge
- Page 157 and 158: A Challenge from Textbook Bioenerge
- Page 159 and 160: A Challenge from Textbook Bioenerge
- Page 161 and 162: A Challenge from Textbook Bioenerge
- Page 163 and 164: A Challenge from Textbook Bioenerge
- Page 165 and 166: 160 The Mitochondrial Free Radical
- Page 167 and 168: 162 The Mitochondrial Free Radical
- Page 169 and 170: 164 The Mitochondrial Free Radical
- Page 171 and 172: 166 The Mitochondrial Free Radical
- Page 173: 168 The Mitochondrial Free Radical
- Page 177 and 178: CHAPTER 14 Ablation of Anaerobic Ce
- Page 179 and 180: Ablation of Anaerobic Cells: Techni
- Page 181 and 182: CHAPTER 15 Transgenic Copies of mtD
- Page 183 and 184: Transgenic Copies of mtDNA: Techniq
- Page 185 and 186: Transgenic Copies of mtDNA: Techniq
- Page 187 and 188: Transgenic Copies of mtDNA: Techniq
- Page 189 and 190: Transgenic Copies of mtDNA: Techniq
- Page 191 and 192: Transgenic Copies of mtDNA: Techniq
- Page 193 and 194: CHAPTER 16 Prospective Impact on th
- Page 195 and 196: Prospective Impact on the Healthy H
- Page 197 and 198: Prospective Impact on the Healthy H
- Page 199 and 200: 196 The Mitochondrial Free Radical
- Page 201 and 202: 198 The Mitochondrial Free Radical
- Page 203 and 204: Index Symbols “~”, 19 A Acetald
- Page 205 and 206: Index Copper 35, 107 see also trans
- Page 207 and 208: Index Heart comparison to man-made
- Page 209 and 210: Index genetic code 23, 115-118, 177
- Page 211 and 212: Index Perhydroxyl radical 41, 122,
- Page 213 and 214: Index protonation see protonation (
- Page 215: MOLECULAR BIOLOGY INTELLIGENCE UNIT
Prospects for Intervention<br />
Fig. 13.1. See opposite page.<br />
13.2. A Way to Obviate mtDNA<br />
<strong>The</strong> proteins encoded in the mtDNA are vital, integral components <strong>of</strong> the OXPHOS<br />
machinery. In rejecting option i, I have thus already accepted that these genes are indispensable.<br />
What is not so clear, however, is that they need to be carried in mitochondria.<br />
Could we not make copies <strong>of</strong> those genes and incorporate them into cells’ nuclear DNA?<br />
169